IT1251144B - Derivati del benzimidazolone - Google Patents

Derivati del benzimidazolone

Info

Publication number
IT1251144B
IT1251144B ITMI912118A ITMI912118A IT1251144B IT 1251144 B IT1251144 B IT 1251144B IT MI912118 A ITMI912118 A IT MI912118A IT MI912118 A ITMI912118 A IT MI912118A IT 1251144 B IT1251144 B IT 1251144B
Authority
IT
Italy
Prior art keywords
alkyl
substituted
mono
optionally
cyan
Prior art date
Application number
ITMI912118A
Other languages
English (en)
Inventor
Franco Borsini
Marco Turconi
Maura Bignotti
Original Assignee
Boehringer Ingelheim Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Italia filed Critical Boehringer Ingelheim Italia
Publication of ITMI912118A0 publication Critical patent/ITMI912118A0/it
Priority to ITMI912118A priority Critical patent/IT1251144B/it
Priority to MX9204139A priority patent/MX9204139A/es
Priority to TW081105974A priority patent/TW209862B/zh
Priority to IL10266592A priority patent/IL102665A/en
Priority to IE246492A priority patent/IE922464A1/en
Priority to PH44739A priority patent/PH30998A/en
Priority to ZA925682A priority patent/ZA925682B/xx
Priority to HU9400255A priority patent/HUT70195A/hu
Priority to PL92302163A priority patent/PL171329B1/pl
Priority to EP92830427A priority patent/EP0526434B1/en
Priority to NZ243777A priority patent/NZ243777A/en
Priority to RU9294015171A priority patent/RU2096411C1/ru
Priority to JP50345393A priority patent/JP2989667B2/ja
Priority to DK92830427T priority patent/DK0526434T3/da
Priority to UA94005462A priority patent/UA42684C2/uk
Priority to ES92830427T priority patent/ES2144412T3/es
Priority to PT92830427T priority patent/PT526434E/pt
Priority to SG1996004034A priority patent/SG52407A1/en
Priority to CZ94170A priority patent/CZ281511B6/cs
Priority to DE69230926T priority patent/DE69230926T2/de
Priority to AT92830427T priority patent/ATE191910T1/de
Priority to AU24275/92A priority patent/AU665366B2/en
Priority to SK101-94A priority patent/SK279292B6/sk
Priority to CA002114542A priority patent/CA2114542C/en
Priority to PCT/IT1992/000088 priority patent/WO1993003016A1/en
Priority to KR1019940700293A priority patent/KR100263495B1/ko
Publication of ITMI912118A1 publication Critical patent/ITMI912118A1/it
Priority to NO940306A priority patent/NO304070B1/no
Priority to FI940420A priority patent/FI111460B/fi
Priority to US08/216,742 priority patent/US5576318A/en
Priority to EE9400396A priority patent/EE03070B1/xx
Application granted granted Critical
Publication of IT1251144B publication Critical patent/IT1251144B/it
Priority to HU95P/P00292P priority patent/HU211256A9/hu
Priority to HK98111444A priority patent/HK1010725A1/xx
Priority to GR20000401632T priority patent/GR3033947T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Derivati del benzimidazolone attivi come recettori 5-HT1A e 5-HT2 nel trattamento dei disturbi del sistema nervoso centrale, aventi formula (I) (FORMULA I) in cui R1 e R2 sono alogeno, trifluorometile, alchile C1-6, alcossile C1-6, alchiltio C1-6, acile C1-6, carbossile, alcossicarbonile C1-6, ossidrile, nitro, amino facoltativamente N-mono o disostituito con un alchile C1-4, acilamino C1-6, alcossicarbonilamino C1-6, carbamoile facoltativamente N-mono o disostituito con alchile C1-4, ciano, alchilsulfinile C1-6, alchilsulfonile C1-6, aminosulfonile facoltativamente N-mono o disostituito con alchile C1-4, amino sulfonilamino N-mono o disostituito con alchile C1-4, aminosulfonilamino; R3 è idrogeno, alchile C1-6, alchenile C2-6 o alchinile C2-6; A è -CC-, -CONH o è assente; B è alchile C2-6 saturo o insaturo, lineare o samificato; m e n sono un numero intero da 1 a 4; R4 è arile, aralchile, eteroarile o eteroaralchile, ciascun gruppo essendo facoltativamente sostituito con uno o più sostituenti scelti tra alogeno, trifluorometile, ciano; alcossile C1-3 o alchile C1-4, e loro sali di addizione.Processo per preparare tali derivati e composizioni farmaceutiche che li contengono.
ITMI912118A 1991-07-30 1991-07-30 Derivati del benzimidazolone IT1251144B (it)

Priority Applications (33)

Application Number Priority Date Filing Date Title
ITMI912118A IT1251144B (it) 1991-07-30 1991-07-30 Derivati del benzimidazolone
MX9204139A MX9204139A (es) 1991-07-30 1992-07-15 Nuevos derivados de bencimidazolona, procedimiento para su preparacion y composicion farmaceutica que los contiene.
TW081105974A TW209862B (it) 1991-07-30 1992-07-28
IL10266592A IL102665A (en) 1991-07-30 1992-07-28 History of benzimidazolone, their preparation and pharmaceutical preparations containing them
IE246492A IE922464A1 (en) 1991-07-30 1992-07-29 New benzimidazolone derivatives
PH44739A PH30998A (en) 1991-07-30 1992-07-29 Benzimidazolone derivatives.
ZA925682A ZA925682B (en) 1991-07-30 1992-07-29 New benzimidazolone derivatives
PT92830427T PT526434E (pt) 1991-07-30 1992-07-30 Derivados de benzimidazolona como antagonistas 5-ht1a e 5-ht2.
SK101-94A SK279292B6 (sk) 1991-07-30 1992-07-30 Benzimidazolové deriváty 5-ht1a a 5-ht2 antagonist
EP92830427A EP0526434B1 (en) 1991-07-30 1992-07-30 Benzimidazolone derivatives as 5-HT1A and 5-HT2 antagonists
NZ243777A NZ243777A (en) 1991-07-30 1992-07-30 Benzimidazolone derivatives; medicaments and preparatory processes
RU9294015171A RU2096411C1 (ru) 1991-07-30 1992-07-30 Производные бензимидазолона, смеси их изомеров или их кислотно-аддитивные соли в качестве антагониста рецептора 5-ht*00i*00a и 5-нт*002
JP50345393A JP2989667B2 (ja) 1991-07-30 1992-07-30 ５−ＨＴ▲下１▼▲下ａ▼拮抗物質及び５−ＨＴ▲下２▼ 拮抗物質としてのベンゾイミダゾロン誘導体
DK92830427T DK0526434T3 (da) 1991-07-30 1992-07-30 Benzimidazolonderivater som 5-HT1A- og 5-HT2-antagonister
UA94005462A UA42684C2 (uk) 1991-07-30 1992-07-30 Похідні бензимідазолону та їх фізіологічно прийнятні кислотно-адитивні солі
ES92830427T ES2144412T3 (es) 1991-07-30 1992-07-30 Derivados de bencimidazoles como antagonistas de 5-ht1a y 5ht2.
HU9400255A HUT70195A (en) 1991-07-30 1992-07-30 Process for producing benzimidazolone derivatives and pharmaceutical preparations containing them
SG1996004034A SG52407A1 (en) 1991-07-30 1992-07-30 New benzimidazolone derivatives
CZ94170A CZ281511B6 (cs) 1991-07-30 1992-07-30 Benzimidazolonové deriváty jako 5-HT1A a 5-HT2 antagonisté
DE69230926T DE69230926T2 (de) 1991-07-30 1992-07-30 Benzimidazolonderivate als 5-HT1A und 5-HT2-Antagonisten
AT92830427T ATE191910T1 (de) 1991-07-30 1992-07-30 Benzimidazolonderivate als 5-ht1a und 5-ht2- antagonisten
AU24275/92A AU665366B2 (en) 1991-07-30 1992-07-30 Benzimidazolone derivatives as 5-HT1A and 5-HT2 antagonists
PL92302163A PL171329B1 (pl) 1991-07-30 1992-07-30 Sposób wytwarzania nowych pochodnych benzimidazolonu PL PL PL PL PL PL
CA002114542A CA2114542C (en) 1991-07-30 1992-07-30 Benzimidazolone derivatives as 5-ht1a and 5-ht2 antagonists
PCT/IT1992/000088 WO1993003016A1 (en) 1991-07-30 1992-07-30 Benzimidazolone derivatives as 5-ht1a and 5-ht2 antagonists
KR1019940700293A KR100263495B1 (ko) 1991-07-30 1992-07-30 5-ht1a 및 5-ht2 길항제로서의 벤즈이미다졸론 유도체,이의 제조방법 및 이를 함유하는 약제학적 조성물
NO940306A NO304070B1 (no) 1991-07-30 1994-01-28 Benzimidazolon-derivater, farmasöytiske preparater inneholdende dem og anvendelse av dem
FI940420A FI111460B (fi) 1991-07-30 1994-01-28 Menetelmä 5-HT1A- ja 5-HT2-antagonististen bentsimidatsolonijohdannaisten valmistamiseksi
US08/216,742 US5576318A (en) 1991-07-30 1994-03-23 Benzimidazolone derivatives
EE9400396A EE03070B1 (et) 1991-07-30 1994-11-23 Bensimidasolooni derivaadid, meetodid nende saamiseks ja neid ühendeid sisaldav ravim
HU95P/P00292P HU211256A9 (en) 1991-07-30 1995-06-20 New benzimidazolone derivatives
HK98111444A HK1010725A1 (en) 1991-07-30 1998-10-21 Benzimidazolone derivatives as 5-ht1a and 5-ht2 antagonists
GR20000401632T GR3033947T3 (en) 1991-07-30 2000-07-12 Benzimidazolone derivatives as 5-HT1A and 5-HT2 antagonists.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI912118A IT1251144B (it) 1991-07-30 1991-07-30 Derivati del benzimidazolone

Publications (3)

Publication Number Publication Date
ITMI912118A0 ITMI912118A0 (it) 1991-07-30
ITMI912118A1 ITMI912118A1 (it) 1993-01-31
IT1251144B true IT1251144B (it) 1995-05-04

Family

ID=11360463

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI912118A IT1251144B (it) 1991-07-30 1991-07-30 Derivati del benzimidazolone

Country Status (32)

Country Link
US (1) US5576318A (it)
EP (1) EP0526434B1 (it)
JP (1) JP2989667B2 (it)
KR (1) KR100263495B1 (it)
AT (1) ATE191910T1 (it)
AU (1) AU665366B2 (it)
CA (1) CA2114542C (it)
CZ (1) CZ281511B6 (it)
DE (1) DE69230926T2 (it)
DK (1) DK0526434T3 (it)
EE (1) EE03070B1 (it)
ES (1) ES2144412T3 (it)
FI (1) FI111460B (it)
GR (1) GR3033947T3 (it)
HK (1) HK1010725A1 (it)
HU (2) HUT70195A (it)
IE (1) IE922464A1 (it)
IL (1) IL102665A (it)
IT (1) IT1251144B (it)
MX (1) MX9204139A (it)
NO (1) NO304070B1 (it)
NZ (1) NZ243777A (it)
PH (1) PH30998A (it)
PL (1) PL171329B1 (it)
PT (1) PT526434E (it)
RU (1) RU2096411C1 (it)
SG (1) SG52407A1 (it)
SK (1) SK279292B6 (it)
TW (1) TW209862B (it)
UA (1) UA42684C2 (it)
WO (1) WO1993003016A1 (it)
ZA (1) ZA925682B (it)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1251144B (it) * 1991-07-30 1995-05-04 Boehringer Ingelheim Italia Derivati del benzimidazolone
US5266571A (en) * 1992-01-09 1993-11-30 Amer Moh Samir Treatment of hemorrhoids with 5-HT2 antagonists
SE9201138D0 (sv) * 1992-04-09 1992-04-09 Astra Ab Novel phthalimidoalkylpiperazines
DK148392D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Heterocykliske forbindelser
ATE201403T1 (de) * 1993-03-16 2001-06-15 Pfizer Naphtalinderivate
JP3719612B2 (ja) * 1993-06-14 2005-11-24 塩野義製薬株式会社 ヘテロ環を含有する尿素誘導体
IL114027A (en) 1994-06-08 1999-11-30 Lundbeck & Co As H 4-Phenyl piperazine (piperidine or tetrahydropyridine) derivatives serotinin 5-HT1A and dopamin D2 receptor ligand pharmaceutical compositions containing them
MX9606450A (es) * 1994-06-14 1997-03-29 Pfizer Derivados de bencimidazolona.
ATE242220T1 (de) * 1994-08-05 2003-06-15 Pfizer Benzimidazolderivate mit dopaminerger wirkung
US5883094A (en) * 1995-04-24 1999-03-16 Pfizer Inc. Benzimidazolone derivatives with central dopaminergic activity
US5889010A (en) * 1995-05-18 1999-03-30 Pfizer Inc. Benzimidazole derivatives having dopaminergic activity
AU7478496A (en) * 1995-10-31 1997-05-22 Merck & Co., Inc. Muscarine antagonists
JP2002518382A (ja) * 1998-06-15 2002-06-25 アメリカン・ホーム・プロダクツ・コーポレイション セロトニン作動薬としてのシクロアルキル−置換アリール−ピペラジン、ピペリジンおよびテトラヒドロピリジン
US6376494B1 (en) 1998-06-15 2002-04-23 American Home Products Corporation Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
AR022303A1 (es) 1999-01-22 2002-09-04 Lundbeck & Co As H Derivados de piperidina, tetrahidropiridina y piperazina, su preparacion y utilizacion
IT1313625B1 (it) * 1999-09-22 2002-09-09 Boehringer Ingelheim Italia Derivati benzimidazolonici aventi affinita' mista per i recettori diserotonina e dopamina.
US6586435B2 (en) 2000-09-19 2003-07-01 Boehringer Ingelheim Pharma Kg Benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors
US6521623B1 (en) 2000-09-19 2003-02-18 Boehringer Ingelheim Pharma Kg N,N'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors
MXPA03002370A (es) * 2000-09-19 2003-10-15 Boehringer Ingelheim Pharma Nuevos derivados bencimidazolona n,n'-disustituidos con afinidad en los receptores de serotonina y dopamina.
WO2002024662A1 (en) * 2000-09-19 2002-03-28 Boehringer Ingelheim Pharma Gmbh & Ko. Kg New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors
JP5080716B2 (ja) 2001-07-20 2012-11-21 サイコジェニックス・インコーポレーテッド 注意欠陥・多動性障害の治療
US7183410B2 (en) * 2001-08-02 2007-02-27 Bidachem S.P.A. Stable polymorph of flibanserin
DK1414816T3 (da) * 2001-08-02 2005-04-11 Bidachem Spa Stabil polymorf af flibanserin, teknisk fremgangsmåde til fremstilling deraf og anvendelse deraf til lægemiddelfremstilling
DE10138273A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Arzneimittel mit neuroprotektiver Wirkung
US20030060475A1 (en) * 2001-08-10 2003-03-27 Boehringer Ingelheim Pharma Kg Method of using flibanserin for neuroprotection
UA78974C2 (en) * 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
US20040048877A1 (en) * 2002-05-22 2004-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions containing flibanserin
NZ537253A (en) * 2002-05-22 2007-09-28 Boehringer Ingelheim Pharma Coated pharmaceutical compositions containing flibanserin polymorph A
WO2004026864A1 (en) * 2002-09-17 2004-04-01 Warner-Lambert Company Llc Heterocyclic substituted piperazines for the treatment of schizophrenia
BRPI0414105B8 (pt) * 2003-09-03 2021-05-25 Askat Inc compostos de benzimidazolona com atividade agonista do receptor 5-ht4
US20050239798A1 (en) * 2004-04-22 2005-10-27 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the treatment of premenstrual and other female sexual disorders
KR20070014184A (ko) * 2004-04-22 2007-01-31 베링거 인겔하임 인터내셔날 게엠베하 성기능 장애 치료용 신규 약제학적 조성물 ⅱ
EP1758891A2 (en) * 2004-06-15 2007-03-07 Pfizer Japan Inc. Benzimidazolone carboxylic acid derivatives
US7737163B2 (en) * 2004-06-15 2010-06-15 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
US20060014757A1 (en) * 2004-07-14 2006-01-19 Boehringer Ingelheim Pharmaceuticals Method for the treatment of anorexia nervosa
US20060025420A1 (en) * 2004-07-30 2006-02-02 Boehringer Ingelheimn International GmbH Pharmaceutical compositions for the treatment of female sexual disorders
WO2006024471A1 (en) * 2004-09-03 2006-03-09 Boehringer Ingelheim International Gmbh Method for the treatment of attention deficit hyperactivity disorder
BRPI0607456A2 (pt) * 2005-02-22 2009-09-08 Pfizer derivados de oxindol como agonistas do receptor 5ht4
CA2599721A1 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of depression
WO2006096439A2 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
US20060199805A1 (en) * 2005-03-04 2006-09-07 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
JP2008540356A (ja) * 2005-05-06 2008-11-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 薬物乱用の治療方法
JP2008540672A (ja) * 2005-05-19 2008-11-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 病状に起因する性的機能不全の治療方法
WO2006125042A1 (en) * 2005-05-19 2006-11-23 Boehringer Ingelheim International Gmbh Method for the treatment of drug-induced sexual dysfunction
WO2007014929A1 (en) 2005-08-03 2007-02-08 Boehringer Ingelheim International Gmbh Use of flibanserin in the treatment of obesity
US7790726B2 (en) * 2005-08-16 2010-09-07 Chemocentryx, Inc. Monocyclic and bicyclic compounds and methods of use
US20070123540A1 (en) * 2005-10-29 2007-05-31 Angelo Ceci Sexual desire enhancing medicaments comprising benzimidazolone derivatives
WO2007048803A1 (en) * 2005-10-29 2007-05-03 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
US20070105869A1 (en) * 2005-11-08 2007-05-10 Stephane Pollentier Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
EP1988897A1 (en) * 2006-02-20 2008-11-12 Boehringer Ingelheim International GmbH Benzimidazolone derivatives for the treatment of urinary incontinence
JPWO2007099828A1 (ja) * 2006-02-23 2009-07-16 塩野義製薬株式会社 環式基で置換された含窒素複素環誘導体
EP1991228A1 (en) * 2006-02-28 2008-11-19 Boehringer Ingelheim International GmbH Treatment of prevention of valvular heart disease with flibanserin
KR20090005371A (ko) * 2006-05-09 2009-01-13 베링거 인겔하임 인터내셔날 게엠베하 폐경후 성욕 장애의 치료를 위한 플리반세린의 용도
WO2008000760A1 (en) * 2006-06-30 2008-01-03 Boehringer Ingelheim International Gmbh Flibanserin for the treatment of urinary incontinence and related diseases
JP2009543839A (ja) * 2006-07-14 2009-12-10 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 女性の性的障害を治療するためのフリバンセリンの使用
CL2007002214A1 (es) 2006-08-14 2008-03-07 Boehringer Ingelheim Int Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
EP2054041A2 (en) 2006-08-14 2009-05-06 Boehringer Ingelheim International GmbH Formulations of flibanserin and method for manufacturing the same
CN101505736A (zh) 2006-08-25 2009-08-12 贝林格尔.英格海姆国际有限公司 控制释放系统及其制造方法
US8722682B2 (en) 2006-12-20 2014-05-13 Sprout Pharmaceuticals, Inc. Sulfated benzimidazolone derivatives having mixed serotonin receptor affinity
JP5087011B2 (ja) * 2007-01-23 2012-11-28 馨 井上 眼疾患モデル用非ヒト動物
WO2008140239A1 (en) * 2007-05-11 2008-11-20 Korea Research Institute Of Chemical Technology Imidazole derivatives having aryl piperidine substituent, method for preparation thereof and pharmaceutical compositions containing same
PE20091188A1 (es) 2007-09-12 2009-08-31 Boehringer Ingelheim Int Compuesto 1-[2-(4-(3-trifluorometil-fenil)piperazin-1-il)etil]-2,3-dihidro-1h-benzimidazol-2-ona (flibanserina), sus sales de adicion y composiciones farmaceuticas que los contienen
US20110028490A1 (en) * 2008-01-24 2011-02-03 Neurosearch A/S 4-phenyl-piperazin-1-yl-alkyl-benzoimidazol-2-one derivatives and their use as monoamine neurotransmitter re-uptake in-hibitors
EP2090297A1 (en) 2008-02-13 2009-08-19 Boehringer Ingelheim International GmbH Formulations of flibanserin
CA2686480A1 (en) * 2008-12-15 2010-06-15 Boehringer Ingelheim International Gmbh New salts
WO2010146595A2 (en) * 2009-06-16 2010-12-23 Symed Labs Limited Novel polymorphs of flibanserin hydrochloride
BRPI1003506B1 (pt) 2010-09-24 2019-12-03 Ache Int Bvi Ltd composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a
WO2014059265A1 (en) * 2012-10-11 2014-04-17 Southern Research Institute Urea and amide derivatives of aminoalkylpiperazines and use thereof
CN104926734B (zh) * 2015-07-07 2017-04-05 苏州立新制药有限公司 氟班色林的制备方法
WO2017076213A1 (zh) * 2015-11-02 2017-05-11 苏州旺山旺水生物医药有限公司 苯并咪唑类化合物、其制备方法及用途
WO2017076356A1 (zh) * 2015-11-05 2017-05-11 苏州晶云药物科技有限公司 氟班色林的新晶型及其制备方法
CN106749038A (zh) * 2015-11-25 2017-05-31 山东诚创医药技术开发有限公司 一种氟班色林的制备方法
CN106866546A (zh) * 2015-12-10 2017-06-20 常州爱诺新睿医药技术有限公司 氟班色林或其药学上可接受的盐与药用辅料的固体分散体及其制备方法
WO2017128932A1 (zh) 2016-01-31 2017-08-03 孟晓明 氟班色林的新晶型及其制备方法及其用途
WO2017133337A1 (zh) * 2016-02-02 2017-08-10 深圳市塔吉瑞生物医药有限公司 一种取代的苯并咪唑酮化合物及包含该化合物的组合物
CN107235913B (zh) * 2016-03-29 2020-07-10 苏州科伦药物研究有限公司 工业规模高效制造优质氟班色林的方法
CN106866582A (zh) * 2017-01-10 2017-06-20 广州隽沐生物科技有限公司 一种氟班色林中间体的制备方法
HU231283B1 (hu) 2018-08-01 2022-09-28 Richter Gedeon Nyrt Eljárás a flibanserin többlépéses folyamatos áramú előállítására
CA3211341A1 (en) * 2021-03-19 2022-09-22 Centre National De La Recherche Scientifique Applications of biased ligands of the serotonin 5-ht7 receptor for the treatment of pain, multiple sclerosis and the control of thermoregulation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3406178A (en) * 1964-02-04 1968-10-15 Monsanto Chem Australia Ltd Preparation of 2-substituted benzimidazoles
US3362956A (en) * 1965-08-19 1968-01-09 Sterling Drug Inc 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines
YU39992B (en) * 1976-04-02 1985-06-30 Janssen Pharmaceutica Nv Process for obtaining new piperazine and piperidine derivatives
IL57569A0 (en) * 1978-06-20 1979-10-31 Synthelabo Phenylpiperazine derivative,their preparation and pharmaceutical compositions containing them
IT1176613B (it) * 1984-08-14 1987-08-18 Ravizza Spa Derivati piperazinici farmacologicamente attivi e processo per la loro preparazione
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
GB8607294D0 (en) * 1985-04-17 1986-04-30 Ici America Inc Heterocyclic amide derivatives
NL8601494A (nl) * 1985-06-22 1987-01-16 Sandoz Ag Thiazolen, hun bereiding en farmaceutische preparaten die ze bevatten.
GB8601160D0 (en) * 1986-01-17 1986-02-19 Fujisawa Pharmaceutical Co Heterocyclic compounds
US5036088A (en) * 1986-06-09 1991-07-30 Pfizer Inc. Antiallergy and antiinflammatory agents, compositions and use
JPH0784462B2 (ja) * 1986-07-25 1995-09-13 日清製粉株式会社 ベンゾイミダゾ−ル誘導体
US4954503A (en) * 1989-09-11 1990-09-04 Hoechst-Roussel Pharmaceuticals, Inc. 3-(1-substituted-4-piperazinyl)-1H-indazoles
IT1251144B (it) * 1991-07-30 1995-05-04 Boehringer Ingelheim Italia Derivati del benzimidazolone

Also Published As

Publication number Publication date
EP0526434A1 (en) 1993-02-03
HK1010725A1 (en) 1999-06-25
TW209862B (it) 1993-07-21
EE03070B1 (et) 1998-02-16
KR100263495B1 (ko) 2000-11-01
FI940420A (fi) 1994-01-28
EP0526434B1 (en) 2000-04-19
ATE191910T1 (de) 2000-05-15
JP2989667B2 (ja) 1999-12-13
CA2114542A1 (en) 1993-02-18
PL171329B1 (pl) 1997-04-30
HUT70195A (en) 1995-09-28
IE922464A1 (en) 1993-02-10
SK279292B6 (sk) 1998-09-09
WO1993003016A1 (en) 1993-02-18
GR3033947T3 (en) 2000-11-30
US5576318A (en) 1996-11-19
ZA925682B (en) 1994-01-31
NO940306L (no) 1994-03-14
AU665366B2 (en) 1996-01-04
PH30998A (en) 1997-12-23
DE69230926D1 (de) 2000-05-25
UA42684C2 (uk) 2001-11-15
IL102665A (en) 1996-10-31
CZ281511B6 (cs) 1996-10-16
DE69230926T2 (de) 2000-10-05
JPH06509575A (ja) 1994-10-27
SG52407A1 (en) 1998-09-28
NO940306D0 (no) 1994-01-28
HU9400255D0 (en) 1994-05-30
SK10194A3 (en) 1994-12-07
DK0526434T3 (da) 2000-07-17
FI940420A0 (fi) 1994-01-28
ITMI912118A1 (it) 1993-01-31
ES2144412T3 (es) 2000-06-16
PL302163A1 (en) 1994-07-11
FI111460B (fi) 2003-07-31
CZ17094A3 (en) 1994-05-18
NO304070B1 (no) 1998-10-19
RU2096411C1 (ru) 1997-11-20
CA2114542C (en) 2004-02-24
MX9204139A (es) 1993-01-01
NZ243777A (en) 1995-04-27
ITMI912118A0 (it) 1991-07-30
HU211256A9 (en) 1995-11-28
PT526434E (pt) 2000-08-31
AU2427592A (en) 1993-03-02

Similar Documents

Publication Publication Date Title
IT1251144B (it) Derivati del benzimidazolone
MX9203249A (es) Derivados del acido bencimidazolin-2-oxo-1-carboxilico y composiciones farmaceuticas que los contienen.
HUT61289A (en) Process for producing pyrimidine derivatives of sulfonamides and pharmaceutical compositions comprising same
DE3882614T2 (de) Indol-Derivate.
NO893205D0 (no) Kjemiske forbindelser.
DE69431069T2 (de) Cyclische amidderivate als neurokinin a antagonisten
IT1264817B1 (it) Derivati di polialchil-4-piperidinoli atti all'impderivati di polialchil-4-piperidinoli atti all'impiego come stabilizzanti per materiali organici iego come stabilizzanti per materiali organici
KR920701120A (ko) 치환된 비시클로헵탄디온 유도체
AR019438A1 (es) Compuesto derivado de piperazina, usos del mismo y metodos para su fabricacion
AR009144A1 (es) Compuestos heterociclicos guanidilamino, composicion farmaceutica que comprende dicho compuesto y uso del mismo para la fabricacion de un medicamento
YU48094B (sh) Derivati fenoksietilamina i postupak za njihovo dobijanje
DE3781783T2 (de) N-alkyl-derivate von 2-amino-6,7-dimethoxytetralin, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen mit antihypertensiver wirkung.
DK0521766T3 (da) Hidtil ukendt fremgangsmåde til syntese af enantiomerer af 3-aminochromanderivater
MX9405318A (es) Pirimidonas e imidazolinonas para tratamiento del choque.
YU38498A (sh) Derivati 2-(arilfenil)amino-imidazolina
TH27321A (th) ไบรไคเนติกออก เซไดเอซอล

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970627